Clinical research on probiotics and prebiotics has burgeoned, unveiling promising insights into their health benefits. Probiotics, live microorganisms providing health advantages when ingested in adequate amounts, have shown efficacy in alleviating gastrointestinal disorders, bolstering immunity, and even modulating mental health conditions. Prebiotics, non-digestible fibers that nourish beneficial gut bacteria, play a crucial role in supporting probiotic activity and overall gut health. Clinical studies highlight their potential in managing conditions like irritable bowel syndrome, inflammatory bowel disease, and allergies. Additionally, emerging research explores their impact on metabolic health and weight management. As scientific understanding deepens, probiotics and prebiotics continue to garner attention as potential therapeutic interventions for various health concerns, emphasizing the importance of ongoing clinical investigation in this field.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India